ClinicalTrials.Veeva

Menu

Physiology of Helmet vs. Facemask Noninvasive Ventilation

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

Acute Hypoxemic Respiratory Failure

Treatments

Device: Noninvasive ventilation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The optimal noninvasive management of acute hypoxemic respiratory failure is debated. Helmet noninvasive ventilation may be more effective than facemask noninvasive ventilation for these patients. Putatitve benefits of helmet use are the possibility to apply significantly higher positive end-expiratory pressure without air leaks and with good patient's comfort.

In this randomized crossover study, the investigators will assess the physiological effects of helmet compared to facemask noninvasive ventilation, with the latter applied with different ventilator settings (similar to or different from helmet settings).

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute hypoxemic respiratory failure and PaO2/FiO2<200 mmHg
  • PaCO2<45 mmHg
  • Respiratory failure not caused by exacerbation of chronic pulmonary disease, cardiac failure or fluid overload

Exclusion criteria

  • Pregnancy
  • Contraindication to helmet or facemask noninvasive ventilation
  • Contraindication to esophageal manometry
  • Contraindication to electrical-impedance tomography monitoring
  • Recent surgery involving the abdomen or the thorax
  • Pneumothorax or documented barotrauma

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

20 participants in 3 patient groups

Helmet noninvasive ventilation
Experimental group
Description:
1-hour treatment with helmet noninvasive ventilation (PEEP 12 cmH2O + pressure support 10 cmH2O).
Treatment:
Device: Noninvasive ventilation
Facemask noninvasive ventilation (facemask settings)
Active Comparator group
Description:
1-hour treatment with facemask noninvasive ventilation (PEEP 5 cmH2O + pressure support 10 cmH2O).
Treatment:
Device: Noninvasive ventilation
Facemask noninvasive ventilation (helmet settings)
Active Comparator group
Description:
1-hour treatment with facemask noninvasive ventilation (PEEP 12 cmH2O + pressure support 10 cmH2O).
Treatment:
Device: Noninvasive ventilation

Trial contacts and locations

1

Loading...

Central trial contact

Domenico L Grieco, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems